Role of dendritic cells in drug allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 4, 2011, Pages 279-284

  Blázquez, Ana B ^a   Cuesta, Javier ^b   Mayorga, Cristobalina ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

dendritic cells; drug allergy; immune mechanisms

Indexed keywords

BETA LACTAM; DRUG METABOLITE; HAPTEN; IMMUNOGLOBULIN E ANTIBODY; PENICILLIN G; SULFAMETHOXAZOLE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANAPHYLAXIS; ANTIGEN PRESENTATION; CELL DAMAGE; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG PROTEIN BINDING; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REACTIVATION;

ANTIGEN PRESENTATION; BIOTRANSFORMATION; DENDRITIC CELLS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HAPTENS; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN E; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES;

EID: 79960841372     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283489bab     Document Type: Review

References (58)

1. Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548-S559.
2. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-693.
3. Park BK, Naisbitt DJ, Gordon SF, et al. Metabolic activation in drug allergies. Toxicology 2001; 158:11-23. (Pubitemid 32119492)
4. Uetrecht J. Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction. Drug Metab Rev 2006; 38:745-753. (Pubitemid 44903266)
5. Merk HF, Abel J, Baron JM, Krutmann J. Molecular pathways in dermatotoxicology. Toxicol Appl Pharmacol 2004; 195:267-277. (Pubitemid 38338647)
6. Castell JV, Castell M. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol 2006; 6:258-265. (Pubitemid 44510181)
7. Tuschl G, Lauer B, Mueller SO. Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opin Drug Metab Toxicol 2008; 4:855-870.
8. Park JJ, Choi YD, Lee JB, et al. Psoriasiform drug eruption induced by antituberculosis medication: potential role of plasma-cytoid dendritic cells. Acta Derm Venereol 2010; 90:305-306.
9. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209:123-129.
10. Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008; 21:84-92. (Pubitemid 351219710)
11. Torres MJ, Romano A, Mayorga C, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56:850-856. (Pubitemid 32800391)
12. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006; 117:404-410. (Pubitemid 43190154)
13. Luque I, Leyva L, Jose Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56:611-618. (Pubitemid 32575434)
14. Landsteiner K, Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935; 61:643-656.
15. Parker CW. Allergic reactions in man. Pharmacol Rev 1982; 34:85-104. (Pubitemid 13040058)
16. de Haan P, de Jonge AJ, Verbrugge T, Boorsma DM. Three epitope-specific monoclonal antibodies against the hapten penicillin. Int Arch Allergy Appl Immunol 1985; 76:42-46. (Pubitemid 15155487)
17. Mayorga C, Obispo T, Jimeno L, et al. Epitope mapping of beta-lactam antibiotics with the use of monoclonal antibodies. Toxicology 1995; 97: 225-234.
18. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:991-1045. (Pubitemid 24140436)
19. Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2:301-305. (Pubitemid 36869638)
20. Merk HF. Drug skin metabolites and allergic drug reactions. Curr Opin Allergy Clin Immunol 2009; 9:311-315.
21. Kim SH, Ye YM, Palikhe NS, et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010; 10:280-290.
22. Barber GN. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 2011; 23:10-20.
23. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005; 23:975-1028. (Pubitemid 40563191)
24. Andreu I, Mayorga C, Miranda MA. Metabolomics in drug intolerance. Curr Drug Metab 2009; 10:947-955.
25. Baron JM, Holler D, Schiffer R, et al. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol 2001; 116:541-548 (Pubitemid 32299843)
26. Baron JM, Merk HF. Drug metabolism in the skin. Curr Opin Allergy Clin Immunol 2001; 1:287-291.
27. Saeki M, Saito Y, Nagano M, et al. mRNA expression of multiple cytochrome p450 isozymes in four types of cultured skin cells. Int Arch Allergy Immunol 2002; 127:333-336. (Pubitemid 34522823)
28. Sanderson JP, Naisbitt DJ, Park BK. Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J 2006; 8:E55-E64. (Pubitemid 44603864)
29. Sieben S, Baron JM, Blomeke B, Merk HF. Multiple cytochrome P450- isoenzymes mRNA are expressed in dendritic cells. Int Arch Allergy Immunol 1999; 118:358-361. (Pubitemid 29195572)
30. Seguin B, Uetrecht J. The danger hypothesis applied to idiosyncratic drug reactions. Curr Opin Allergy Clin Immunol 2003; 3:235-242. (Pubitemid 37010877)
31. Boisleve F, Kerdine-Romer S, Rougier-Larzat N, Pallardy M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signaling pathways: role of TNF-alpha and MAPK. J Invest Dermatol 2004; 123:494-502. (Pubitemid 39095620)
32. Ade N, Antonios D, Kerdine-Romer S, et al. NF-kappaB plays a major role in the maturation of human dendritic cells induced by NiSO(4) but not by DNCB. Toxicol Sci 2007; 99:488-501. (Pubitemid 351753065)
33. Sanderson JP, Naisbitt DJ, Farrell J, et al. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 2007; 178:5533-5542. (Pubitemid 46674348)
34. Rodriguez-Pena R, Lopez S, Mayorga C, et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006; 118:949-956. (Pubitemid 44498760)
35. Watanabe T, Nakashima H, Ohmatsu H, et al. Detection of human herpesvirus- 6 transcripts in carbamazepine-induced hypersensitivity syndrome by in situ hybridization. J Dermatol Sci 2009; 54:134-136.
36. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106:769-776.
37. Cornejo-Garcia JA, Fernandez TD, Torres MJ, et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007; 62:1429-1438. (Pubitemid 350045598)
38. Posadas SJ, Torres MJ, Mayorga C, et al. Gene expression levels of cytokine profile and cytotoxic markers in nonimmediate reactions to drugs. Blood Cells Mol Dis 2002; 29:179-189.
39. Torres MJ, Mayorga C, Fernandez TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19:119-130.
40. Arrighi JF, Rebsamen M, Rousset F, et al. A critical role for p38 mitogenactivated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 2001; 166:3837-3845. (Pubitemid 32224909)
41. Lopez S, Torres MJ, Rodriguez-Pena R, et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2009; 160:259-265.
42. Antunez C, Barbaud A, Gomez E, et al. Recognition of iodixanol by dendritic cells increases the cellular response in delayed allergic reactions to contrast media. Clin Exp Allergy 2011; 41:657-664.
43. Sugita K, Tohyama M, Watanabe H, et al. Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome. J Allergy Clin Immunol 2010; 126:408-410.
44. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140:183-188. (Pubitemid 38500330)
45. Korsgren M. NK cells and asthma. Curr Pharm Des 2002; 8:1871-1876.
46. French AR, Yokoyama WM. Natural killer cells and autoimmunity. Arthritis Res Ther 2004; 6:8-14. (Pubitemid 38256082)
47. Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114:1209-1215. (Pubitemid 39469167)
48. Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14:1343-1350.
49. Walzer T, Dalod M, Robbins SH, et al. Natural-killer cells and dendritic cells: 'l'union fait la force'. Blood 2005; 106:2252-2258. (Pubitemid 41510793)
50. Marcenaro E, Ferranti B, Moretta A. NK-DC interaction: on the usefulness of auto-aggression. Autoimmun Rev 2005; 4:520-525. (Pubitemid 41415763)
51. FerlazzoG, Pack M, Thomas D, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004; 101:16606-16611. (Pubitemid 39557760)
52. Vitale M, Della Chiesa M, Carlomagno S, et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004; 34:1715-1722. (Pubitemid 39256054)
53. Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: do 'NK-reg cells' exist? Cell Mol Immunol 2006; 3:241-254.
54. Chaves P, Torres MJ, Aranda A, et al. Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams. Allergy 2010; 65:1600-1608.
55. Torres MJ, Mayorga C, Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009; 19:80-90.
56. Torres MJ, Corzo JL, Leyva L, et al. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol Dis 2003; 30:124-131. (Pubitemid 36378874)
57. Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988; 18:515-540. (Pubitemid 19000201)
58. Aihara Y, Ito SI, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149:165-169. (Pubitemid 36966528)